Case Study: Organon builds an ESG strategy from scratch with Datamaran

Building ESG strategy in a global pharma business

Organon, a global women’s healthcare company spun out of Merck, needed to build an ESG strategy from scratch in a short timeframe. To do this, it turned to Datamaran and its AI-powered ESG platform to help define material issues, benchmark against peers, and create a baseline for reporting and strategy.

Using Datamaran, Organon completed an initial materiality assessment quickly, combined it with stakeholder insights, and aligned its ESG disclosure approach across reporting and governance functions. The result was a data-driven ESG strategy approved by executive leadership and the Board of Directors, with Datamaran continuing to support ongoing monitoring and quarterly board updates.

Organon

Byron Austin

Head of Corporate Responsibility & ESG Management